EU TRANSPARENCY REGISTER · 916467249117-03 · United States

Treatment Action Group

TAG

Category

NGO / platform

Country

United States

New York

Entity form

501C3

Stated objectives

Treatment Action Group (TAG) is an independent, activist, and community-based research and policy think tank fighting to end HIV, tuberculosis (TB), and hepatitis C virus (HCV). TAG envisions the end of the HIV, TB, and HCV pandemics with t…

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2023-02-16

Last updated

2026-01-15

Other NGO / platform in United States

Other registered organisations in United States

Frequently asked questions

What is this organisation?
Treatment Action Group (TAG) is an interest representative listed in the EU Joint Transparency Register under ID 916467249117-03. Entity form: 501C3.
What category is it registered under?
It is registered under the category "Non-governmental organisations, platforms and networks and similar".
Which country is it based in?
The organisation is based in United States, New York.
What are its stated goals?
As declared by the registrant: Treatment Action Group (TAG) is an independent, activist, and community-based research and policy think tank fighting to end HIV, tuberculosis (TB), and hepatitis C virus (HCV). TAG envisions the end of the HIV, TB, and HCV pandemics with t…
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 916467249117-03.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-11 · Commission Reuse Decision 2011/833/EU